Posts Tagged ‘SHL’

  • Sonic Healthcare Acquires US Based Laboratories

    Thursday, August 13th, 2009

    Sonic Healthcare Limited (SHL) is pleased to announce that it has acquired Piedmont Medical Laboratory (PML), based in Winchester, Virginia, and Axiom Laboratories, based in Tampa, Florida. PML was established in 1991 and is a regional laboratory servicing an integrated network of community-based hospitals, physicians and health care providers, in the states of Virginia and West Virginia. The business has experienced steady revenue growth and has current annual revenue of ~US$11 million. PML will become part of Sonic’s existing Mid-Atlantic division, which is based in Chantilly, Virginia, close to Washington, D.C. The operations of PML are contiguous with those of Sonic’s Mid-Atlantic division and the merger of the two operations will add critical mass to Sonic’s operations in this region and will also provide the opportunity for significant synergy capture.

    The purchase price for both businesses comprises upfront cash payments totalling US$20 million and a performance based earn-out of up to US$2.5 million payable over 2 years. The structure of the Axiom acquisition will provide tax deductions for goodwill amortisation over 15 years, with a total net present value to Sonic of ~US$1 million.

    Sonic Healthcare’s CEO and Managing Director, Dr Colin Goldschmidt said: “Both Piedmont Medical Laboratory and Axiom Laboratories represent valuable synergistic acquisitions for Sonic. PML will serve to extend our service in the Mid-Atlantic area and will also offer operating synergies due to the close proximity to our current operation. Axiom adds further critical mass and growth potential for Sonic in the important Florida market.”

    www.sonichealthcare.com

    Post to Twitter

    Sonic Booms

    Wednesday, February 25th, 2009

    Sonic Healthcare (SHL) today reported a record interim net profit of A$137 million for the half year to 31 December 2008, an increase of 21% over the comparative period. The result was achieved on revenues of A$1,439 million, 28% higher than the corresponding period in the prior year. 

    Sonic’s CEO and Managing Director, Dr Colin Goldschmidt, said: “Sonic Healthcare has delivered another strong result for the half year and has shown the resilience of its business against global economic conditions and the current credit crisis.  A particularly pleasing aspect of this result is the strong organic revenue growth of our laboratory operations. We have clearly taken market share in a number of our key markets, including Australia. The efforts of our management teams to identify and capture synergies are also bearing fruit, with strong margin expansion especially in Germany and the USA.” 

    Sonic’s Board has declared an interim dividend of 22 cents per share (franked to 60%), a 10% increase over the previous year’s interim dividend. 

    http://www.sonichealthcare.com/ 

    Post to Twitter